文献速递新发突发、热带与寄生虫病

RTS,S/AS01E疫苗接种者中不同的Th1和Th2反应与疟疾保护和风险相关

Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees.
PubMed 文献 · Clin Infect Dis · 2017-01-01

该研究嵌套于非洲RTS,S/AS01E三期试验的匹配病例对照研究,分析57例临床疟疾病例和152例无疟疾对照的免疫标志物。结果显示IL-5/CSP比值与疫苗接种者疟疾风险升高相关,而TH1相关标志物(IFN-γ、IL-15、GM-CSF)与保护相关。提示IL-5可能是缺乏保护的替代标志,TH1反应可能参与保护机制。

要点

  • RTS,S/AS01E接种者中IL-5/CSP比值升高与疟疾风险增加相关。
  • TH1相关标志物IFN-γ、IL-15和GM-CSF与疟疾保护相关。
  • 第二代疫苗佐剂可考虑增强TH1反应并降低IL-5反应。

核心结论

  • RTS,S/AS01E诱导的IL-5可能是缺乏保护的替代标志,而TH1相关反应可能参与保护机制。

研究设计与样本

  • 匹配病例对照研究,嵌套于多中心非洲RTS,S/AS01E三期试验。
  • 分析57例临床疟疾病例(32例RTS,S/25例对照疫苗)和152例无疟疾对照(106例RTS,S/46例对照疫苗)的儿童和婴儿样本。
  • 免疫后1个月经RTS,S/AS01E抗原刺激后,用Luminex检测30种标志物,分析粗浓度及抗原/背景对照比值。

主要发现

  • IL-2和IL-5比值与RTS,S/AS01E疫苗接种相关(校正P ≤ .01)。
  • IL-5/CSP比值(Th2细胞因子)与RTS,S/AS01E接种者疟疾 odds 升高相关(每增加10% CSP比值,OR=1.17;多重检验校正P=.03)。
  • 多标志物分析中,TH1相关标志物IFN-γ、IL-15和GM-CSF与后续疟疾保护相关,而IL-5和RANTES增加疟疾 odds。

临床怎么用

  • 检测RTS,S/AS01E接种者的IL-5/CSP比值可能有助于识别疟疾风险较高者。
  • TH1相关标志物(IFN-γ、IL-15、GM-CSF)可作为保护相关标志物用于疫苗评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The RTS,S/AS01E malaria vaccine has moderate efficacy, lower in infants than children. Current efforts to enhance RTS,S/AS01E efficacy would benefit from learning about the vaccine-induced immunity and identifying correlates of malaria protection, which could, for instance, inform the choice of adjuvants. Here, we sought cellular immunity-based correlates of malaria protection and risk associated with RTS,S/AS01E vaccination. METHODS: We performed a matched case-control study nested within the multicenter African RTS,S/AS01E phase 3 trial. Children and infant samples from 57 clinical malaria cases (32 RTS,S/25 comparator vaccinees) and 152 controls without malaria (106 RTS,S/46 comparator vaccinees) were analyzed. We measured 30 markers by Luminex following RTS,S/AS01E antigen stimulation of cells 1 month postimmunization. Crude concentrations and ratios of antigen to background control were analyzed. RESULTS: Interleukin (IL) 2 and IL-5 ratios were associated with RTS,S/AS01E vaccination (adjusted P ≤ .01). IL-5 circumsporozoite protein (CSP) ratios, a helper T cell type 2 cytokine, correlated with higher odds of malaria in RTS,S/AS01E vaccinees (odds ratio, 1.17 per 10% increases of CSP ratios; P value adjusted for multiple testing = .03). In multimarker analysis, the helper T cell type 1 (TH1)-related markers interferon-γ, IL-15, and granulocyte-macrophage colony-stimulating factor protected from subsequent malaria, in contrast to IL-5 and RANTES, which increased the odds of malaria. CONCLUSIONS: RTS,S/AS01E-induced IL-5 may be a surrogate of lack of protection, whereas TH1-related responses may be involved in protective mechanisms. Efforts to develop second-generation vaccine candidates may concentrate on adjuvants that modulate the immune system to support enhanced TH1 responses and decreased IL-5 responses.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Moncunill G, Mpina M, Nhabomba AJ, et al. Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees. Clin Infect Dis. 2017. PMID: 28505356. doi:10.1093/cid/cix429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。